Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.08 USD | +2.96% | -4.12% | +2.41% |
Oct. 30 | Harmony Biosciences Holdings Launches Secondary Common Stock Offering | MT |
Oct. 29 | Harmony Biosciences Holdings, Inc., Q3 2024 Earnings Call, Oct 29, 2024 |
Capitalization | 1.89B | P/E ratio 2024 * |
14.2x | P/E ratio 2025 * | 10.4x |
---|---|---|---|---|---|
Enterprise value | 1.55B | EV / Sales 2024 * |
2.19x | EV / Sales 2025 * | 1.56x |
Free-Float |
58.83% | Yield 2024 * |
-
| Yield 2025 * | - |
Last Transcript: Harmony Biosciences Holdings, Inc.
1 day | +2.96% | ||
1 week | -4.12% | ||
Current month | +2.96% | ||
1 month | -7.00% | ||
3 months | +2.10% | ||
6 months | +4.39% | ||
Current year | +2.41% |
Director | Title | Age | Since |
---|---|---|---|
Jeffrey Dayno
CEO | Chief Executive Officer | 66 | 2023-01-05 |
Director of Finance/CFO | 54 | 2021-03-28 | |
Kumar Budur
CTO | Chief Tech/Sci/R&D Officer | 53 | 2024-04-30 |
Manager | Title | Age | Since |
---|---|---|---|
Jeffrey Aronin
CHM | Chairman | 56 | 2017-07-24 |
Antonio Gracias
BRD | Director/Board Member | 53 | 2017-08-31 |
Juan Sabater
BRD | Director/Board Member | 59 | 2016-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.52% | 14 M€ | -3.29% | - | |
0.35% | 28 M€ | +3.20% | ||
0.31% | 26 M€ | +0.50% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+2.96% | -4.12% | +34.31% | -20.77% | 1.89B | ||
-1.30% | -8.26% | +41.12% | +218.84% | 736B | ||
+0.76% | -1.96% | +8.37% | +115.38% | 496B | ||
+0.17% | -0.47% | +6.58% | -3.30% | 386B | ||
-0.16% | +8.36% | +42.08% | +74.68% | 360B | ||
-0.43% | -2.02% | -0.94% | +14.45% | 258B | ||
+1.94% | -2.88% | +14.68% | -25.68% | 253B | ||
-0.18% | -5.03% | +6.37% | +16.92% | 221B | ||
+1.80% | -3.21% | +12.79% | +24.27% | 219B | ||
-0.29% | +0.71% | +19.74% | +48.99% | 172B | ||
Average | +0.53% | -1.89% | +18.51% | +46.38% | 310.29B | |
Weighted average by Cap. | +0.04% | -2.32% | +20.38% | +83.34% |
Financials
(USD)2024 * | 2025 * | |
---|---|---|
Net sales | 711M | 839M |
Net income | 146M | 196M |
Net Debt | -332M | -580M |
Date | Price | Change | Volume |
---|---|---|---|
24-11-01 | 33.08 $ | +2.96% | 5,616,157 |
24-10-31 | 32.13 $ | -4.94% | 4,994,924 |
24-10-30 | 33.80 $ | -18.53% | 2,887,537 |
24-10-29 | 41.49 $ | +16.06% | 1,316,605 |
24-10-28 | 35.75 $ | +3.62% | 809,748 |
Delayed Quote Nasdaq, November 01, 2024 at 04:00 pm EDT
More quotes- Stock Market
- Equities
- HRMY Stock